New York
|
001-9232
|
13- 5658129
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
1065 Avenue of the Americas, New York, New York
|
10018
|
(Address of principal executive offices)
|
(Zip Code)
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
1. |
Election of Directors:
|
||||||
For
|
Withheld
|
Broker Non-Votes
|
|||||
William Turner*
|
13,744,146
|
2,998,173
|
1,855,413
|
||||
Mark Kaplan*
|
13,745,596
|
2,996,723
|
1,855,413
|
||||
Deborah Shaw*
|
13,716,939
|
3,025,380
|
1,855,413
|
||||
Jerome Shaw*
|
15,481,920
|
1,260,399
|
1,855,413
|
||||
Ronald Kochman**
|
13,737,816
|
3,004,503
|
1,855,413
|
||||
Theresa Havell**
|
13,746,201
|
2,996,118
|
1,855,413
|
||||
Bruce Goodman**
|
13,727,177
|
3,015,142
|
1,855,413
|
||||
Lloyd Frank**
|
12,061,760
|
4,680,559
|
1,855,413
|
||||
*one-year term
**two-year term
|
2.
|
Approve, on an Advisory Basis, the Executive Compensation Program for the Company’s Named Executive Officers:
|
||||||
For
|
Against
|
Abstain
|
Broker Non-Votes
|
||||
13,700,975
|
3,018,998
|
22,346
|
1,855,413
|
3.
|
Vote, on an Advisory Basis, on How Often the Company Will Conduct an Advisory Vote on Executive Compensation:
|
||||||||
1 Year
|
2 Years
|
3 Years
|
Abstain
|
Broker Non-Votes
|
|||||
6,759,156
|
8,432,045
|
1,473,029
|
78,089
|
1,855,413
|
4.
|
Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm for fiscal year 2014:
|
||||||
For
|
Against
|
Abstain
|
Broker Non-Votes
|
||||
16,468,786
|
2,122,039
|
6,907
|
0
|
VOLT INFORMATION SCIENCES, INC. | ||
By | /s/ James Whitney Mayhew | |
James Whitney Mayhew, Senior Vice President | ||
and Chief Financial Officer |